Project cooperationUpdated on 23 February 2026
Mathematical T-cell modeller seeks project.
Associate Professor at University of Antwerp
Antwerp, Belgium
About
Our CHERMID group has a decades-long experience with mathematical modeling and in particular with mathematical modeling of immune responses.
We are in particular specialized in modeling longitudinal T-cell and antibody responses using different modeling approaches.
Topic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
New in vitro assay methodologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Hanne Haslene-Hox
Seinor research scientist at SINTEF Industry
Trondheim, Norway
Project cooperation
Modelling of Disease and Treatment
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Gil Katz
Manager, Medical-Computational Collaborations at Institute for Medical BioMathematics (IMBM)
Bene Ataroth, Israel
Project cooperation
Computational prognosis of therapies for solid tumors
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Gianpaolo Ruocco
Professor and CEO at initiatives for Bio-Materials Behavior (iBMB) Srls
Potenza, Italy